Directory
>
Adora Ndu Pharmd Jd
Adora Ndu Pharmd Jd
Board of Directors | Acadia Pharmaceuticals Inc.
United States
Adora Ndu Pharmd Jd
Summary
Adora Ndu is a highly accomplished Chief Regulatory Officer at BridgeBio Pharma, with an impressive background in the biotechnology and pharmaceutical industries. With a Doctor of Pharmacy (PharmD) and a Juris Doctor (JD), she uniquely bridges the gap between healthcare and law. Adora has extensive experience in regulatory affairs, clinical development, and drug policy, having held key positions at notable organizations such as Acadia Pharmaceuticals and Biomarin Pharmaceutical. Her leadership roles on various boards reflect her commitment to advancing medical science and policy. She is also an adjunct faculty member at Johns Hopkins University, where she shares her expertise in biotechnology enterprise. Adora's diverse experience across government, corporate, and academic sectors showcases her adaptability and strategic insight. Her passion for innovation in healthcare is evident in her work, making her a valuable asset in the industry.
Adora Ndu Pharmd Jd
Work Experience
Board of Directors at
Acadia Pharmaceuticals Inc.
October 2022 - Present
Chief Regulatory Affairs Officer at
BridgeBio
January 2022 - Present
Board of Directors at
DBV Technologies
May 2021 - Present
Adjunct Faculty, Masters in Biotechnology Enterprise and Entrepreneurship at
The Johns Hopkins University
January 2019 - Present
Interim Chief Legal Officer at
BridgeBio
October 2022 - September 2023
Group Vice President, R&D Strategy Scientific Collaborations and Policy at
BioMarin Pharmaceutical Inc.
January 2021 - February 2022
Vice President Regulatory Affairs at
BioMarin Pharmaceutical Inc.
March 2019 - December 2020
Executive Director, Regulatory Affairs at
BioMarin Pharmaceutical Inc.
September 2017 - March 2019
Sr. Director at
BioMarin Pharmaceutical Inc.
February 2017 - September 2017
Commander at
Commissioned Corps of the U.S. Public Health Service
January 2008 - January 2016
Division Director (Division of Medical Policy Development), Team lead (OPDP), Safety Reviewer at
FDA
January 2008 - January 2016
Senior Medical Science Liaison at
Procter & Gamble
June 2006 - December 2008
Pharmacy Practice Resident at
MedStar Georgetown University Hospital
January 2005 - January 2006
Adora Ndu Pharmd Jd
Education
January 2018 - January 2018
Howard University, Doctor Of Pharmacy (Pharmd)
University of Maryland Francis King Carey School of Law, Doctor Of Law (J.D.)
Ursuline Academy of Dallas
Frequently Asked Questions about Adora Ndu Pharmd Jd
What company does Adora Ndu Pharmd Jd work for?
Adora Ndu Pharmd Jd is a Board of Directors at Acadia Pharmaceuticals Inc., a company specializing in Biological products, except diagnostic.
Where Adora Ndu Pharmd Jd graduated from?
Adora Ndu Pharmd Jd holds a degree in Executive Education from Harvard Business School.
Who is Adora Ndu Pharmd Jd?
Adora Ndu is a highly accomplished Chief Regulatory Officer at BridgeBio Pharma, with an impressive background in the biotechnology and pharmaceutical industries. With a Doctor of Pharmacy (PharmD) and a Juris Doctor (JD), she uniquely bridges the gap between healthcare and law. Adora has extensive experience in regulatory affairs, clinical development, and drug policy, having held key positions at notable organizations such as Acadia Pharmaceuticals and Biomarin Pharmaceutical. Her leadership roles on various boards reflect her commitment to advancing medical science and policy. She is also an adjunct faculty member at Johns Hopkins University, where she shares her expertise in biotechnology enterprise. Adora's diverse experience across government, corporate, and academic sectors showcases her adaptability and strategic insight. Her passion for innovation in healthcare is evident in her work, making her a valuable asset in the industry.
Adora`s contact details
Colleagues
VP, General Manager Long-term Care
Vice President, Head of Sales - Rare Disease Business
Vice President, Associate General Counsel
Vice President - Drug Safety and Pharmacovigilance
VP, Head of Commercial Insights, Analytics and Operations
Executive Director, Scientific Communications & Medical Information
Executive Director
Executive Director
Client Advisory Board member
Executive Director Marketing Rare Disease